These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Functional Significance of TDP-43 Mutations in Disease. Buratti E Adv Genet; 2015; 91():1-53. PubMed ID: 26410029 [TBL] [Abstract][Full Text] [Related]
5. The role of TDP-43 in the pathogenesis of ALS and FTLD. Baralle M; Buratti E; Baralle FE Biochem Soc Trans; 2013 Dec; 41(6):1536-40. PubMed ID: 24256250 [TBL] [Abstract][Full Text] [Related]
6. TDP-43 Proteinopathy and ALS: Insights into Disease Mechanisms and Therapeutic Targets. Scotter EL; Chen HJ; Shaw CE Neurotherapeutics; 2015 Apr; 12(2):352-63. PubMed ID: 25652699 [TBL] [Abstract][Full Text] [Related]
7. Neurodegeneration. C9ORF72 repeat expansions in mice cause TDP-43 pathology, neuronal loss, and behavioral deficits. Chew J; Gendron TF; Prudencio M; Sasaguri H; Zhang YJ; Castanedes-Casey M; Lee CW; Jansen-West K; Kurti A; Murray ME; Bieniek KF; Bauer PO; Whitelaw EC; Rousseau L; Stankowski JN; Stetler C; Daughrity LM; Perkerson EA; Desaro P; Johnston A; Overstreet K; Edbauer D; Rademakers R; Boylan KB; Dickson DW; Fryer JD; Petrucelli L Science; 2015 Jun; 348(6239):1151-4. PubMed ID: 25977373 [TBL] [Abstract][Full Text] [Related]
8. TDP-43 loss of cellular function through aggregation requires additional structural determinants beyond its C-terminal Q/N prion-like domain. Budini M; Romano V; Quadri Z; Buratti E; Baralle FE Hum Mol Genet; 2015 Jan; 24(1):9-20. PubMed ID: 25122661 [TBL] [Abstract][Full Text] [Related]
9. TDP-43 mutations causing amyotrophic lateral sclerosis are associated with altered expression of RNA-binding protein hnRNP K and affect the Nrf2 antioxidant pathway. Moujalled D; Grubman A; Acevedo K; Yang S; Ke YD; Moujalled DM; Duncan C; Caragounis A; Perera ND; Turner BJ; Prudencio M; Petrucelli L; Blair I; Ittner LM; Crouch PJ; Liddell JR; White AR Hum Mol Genet; 2017 May; 26(9):1732-1746. PubMed ID: 28334913 [TBL] [Abstract][Full Text] [Related]
10. The N-Terminal Domain of ALS-Linked TDP-43 Assembles without Misfolding. Tsoi PS; Choi KJ; Leonard PG; Sizovs A; Moosa MM; MacKenzie KR; Ferreon JC; Ferreon ACM Angew Chem Int Ed Engl; 2017 Oct; 56(41):12590-12593. PubMed ID: 28833982 [TBL] [Abstract][Full Text] [Related]
11. Detection of TDP-43 oligomers in frontotemporal lobar degeneration-TDP. Kao PF; Chen YR; Liu XB; DeCarli C; Seeley WW; Jin LW Ann Neurol; 2015 Aug; 78(2):211-21. PubMed ID: 25921485 [TBL] [Abstract][Full Text] [Related]
12. Converging mechanisms in ALS and FTD: disrupted RNA and protein homeostasis. Ling SC; Polymenidou M; Cleveland DW Neuron; 2013 Aug; 79(3):416-38. PubMed ID: 23931993 [TBL] [Abstract][Full Text] [Related]
13. Alterations in stress granule dynamics driven by TDP-43 and FUS: a link to pathological inclusions in ALS? Aulas A; Vande Velde C Front Cell Neurosci; 2015; 9():423. PubMed ID: 26557057 [TBL] [Abstract][Full Text] [Related]